<html>
<head>PUBMED IDs for BCL-W</head>
<body bgcolor='#C5F0F2'><h1>BCL-W</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15039946/'>Expression of 11 members of the BCL-2 family of apoptosis regulatory molecules during human preimplantation embryo development and fragmentation.</a> March 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15039923/'>Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus.</a> March 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15611130/'>The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.</a> December 22  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/19124064/'>The Bcl-w promoter is activated by beta-catenin/TCF4 in human colorectal carcinoma cells.</a> February 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20457620/'>IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.</a> August 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21772052/'>An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21931276/'>Analysis of apoptosis regulatory genes altered by histone deacetylase inhibitors in chronic lymphocytic leukemia cells.</a> May 9  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22825469/'>Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors.</a> November 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24513107/'>From DARPins to LoopDARPins: novel LoopDARPin design allows the selection of low picomolar binders in a single round of ribosome display.</a> March 26  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25787766/'>Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy.</a> December 22  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25846734/'>miR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W.</a> March 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26013319/'>MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor.</a> May 6  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27048913/'>Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL.</a> August 27  2016<br></body></html>
